Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 317 for:    "Pulmonary Fibrosis, Idiopathic"

Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study (TURK-UIP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02821039
Recruitment Status : Recruiting
First Posted : July 1, 2016
Last Update Posted : April 25, 2018
Sponsor:
Information provided by (Responsible Party):
Turkish Thoracic Society

Brief Summary:
The Turkish Thoracic Society Usual Interstitial Pneumonia Registry (TURK-UIP) is a collaborative project to coordinate a team of investigators from various regions of Turkey. The purpose of the Registry is to collect epidemiological data on patients with idiopathic pulmonary fibrosis and other causes of UIP, and to obtain information about the natural course of the disease and the treatment response.

Condition or disease
Idiopathic Pulmonary Fibrosis Usual Interstitial Pneumonia

Detailed Description:
The TURK-UIP Registry is a web based application that will store information about patients. A HRCT pattern consistent with UIP will be confirmed by 3 radiologists. At the 3-month visits, the pulmonary function tests and the 6-minute walk test will be recorded. Patients will be prospectively followed for a 5-year period.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 3 Years
Official Title: Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
Study Start Date : June 2016
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : December 2021





Primary Outcome Measures :
  1. Number of subjects enrolled with IPF and other causes of UIP [ Time Frame: 5 years ]
    Natural history of course of disease in patients with IPF and other causes of UIP.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects diagnosed with IPF and other causes of UIP.
Criteria

Inclusion Criteria:

  1. Understand and sign the informed consent document.
  2. The presence of a definite or possible UIP pattern on high resolution computed tomography (HRCT) or a histologic UIP pattern (definite, probable and possible) on surgical lung biopsy (as defined by ATS/ERS/JRS/ALAT criteria).

Exclusion Criteria:

  1. HRCT findings inconsistent with UIP pattern (peribronchovascular predominance, extensive ground glass abnormality,profuse micronodules, discrete cysts , consolidation in bronchopulmonary segment(s)/lobe(s), diffuse mosaic attenuation/air-trapping),
  2. Histopathological findings inconsistent with UIP pattern (as defined by ATS/ERS/JRS/ALAT criteria).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02821039


Contacts
Layout table for location contacts
Contact: Benan Müsellim, MD +90 505 8022373 benanmusellim@gmail.com
Contact: Gülfer Okumuş, MD +90 532 2831726 gulferokumus@yahoo.com

  Show 53 Study Locations
Sponsors and Collaborators
Turkish Thoracic Society
Investigators
Layout table for investigator information
Principal Investigator: Benan Müsellim, MD Istanbul University,Cerrahpasa Medical Faculty, Istanbul, Turkey.

Additional Information:

Publications:
Layout table for additonal information
Responsible Party: Turkish Thoracic Society
ClinicalTrials.gov Identifier: NCT02821039     History of Changes
Other Study ID Numbers: TTS-01
First Posted: July 1, 2016    Key Record Dates
Last Update Posted: April 25, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Turkish Thoracic Society:
Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia

Additional relevant MeSH terms:
Layout table for MeSH terms
Fibrosis
Pneumonia
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial
Pathologic Processes
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections